Ozempic can appear to stop working in two distinct ways. The first is a true plateau — weight loss slows and A1C levels off after 6 to 12 months of response, which is expected physiology, not drug failure. The second is apparent failure due to fixable issues: a dose that has not been titrated up, expired or heat-damaged insulin, intramuscular injection misfire, or calorie creep over time. True loss of pharmacologic effect is uncommon. Most investigated cases turn out to be one of these correctable issues or a normal plateau.
Expected Trajectory: What Working Looks Like
| Time Point | Typical Weight Loss | Typical A1C Change |
|---|---|---|
| Week 4 | 1–3% | −0.3 to −0.6 |
| Month 3 | 4–7% | −0.7 to −1.2 |
| Month 6 | 7–11% | −1.0 to −1.5 |
| Month 12 | 10–15% | −1.2 to −1.8 |
| Month 18–24 | Plateau; often 10–15% maintained | Stable around month 12 values |
Hitting a plateau after 12 months with maintained loss is success, not failure. The alternative to a plateau would be either continued loss (uncommon without lifestyle intensification) or regain (the outcome seen in trial extensions when Ozempic is stopped).
Common Reasons Ozempic Seems to Stop Working
1. Never Reached a Therapeutic Dose
Many patients stay at 0.5 mg because it is comfortable and the initial response is good. The fully titrated dose is 1.0 mg (standard) to 2.0 mg (max) for type 2 diabetes. If you are plateauing at 0.5 mg, ask about titrating up.
2. Injection Technique Problems
- Injecting into muscle instead of subcutaneous fat (too-short needles on lean abdomens or too-deep push)
- Pulling the needle out before the 10-second hold, losing part of the dose
- Re-using needles, which dulls the point and underdelivers
- Skipping the pen priming step
3. Storage Problems
- Unopened pens not refrigerated as required
- In-use pens past 56 days (Ozempic) or exposed to high heat
- Frozen pens — once frozen, semaglutide is inactive and should be discarded
4. Missed Doses
Ozempic is once-weekly. Occasional missed doses (more than 5 days past due) reset the steady-state concentration and can blunt effect. The “do not stretch the dosing interval” rule matters.
5. Calorie Creep
After 6 to 12 months, many patients relax the new eating pattern as the novelty of reduced appetite wears off. Higher-calorie liquids (wine, smoothies, sugary coffee) are especially easy to under-count. A 1-week food log usually reveals 300 to 500 kcal of drift.
6. Muscle Loss
GLP-1-induced weight loss without resistance training tends to lose muscle along with fat, which lowers resting metabolic rate. Protein intake (1.2 to 1.6 g per kg body weight) plus resistance training preserves muscle and often restores a slower loss trajectory.
How to Investigate Before Concluding “Stopped Working”
- Compare current dose to the original plan — still at starter dose after 6+ months?
- Review injection log — missed doses, technique, pen age
- Check storage history — refrigerated unopened? Room temp less than 56 days opened?
- Run a 7-day food log (honest) — note calorie creep, liquid calories, weekends
- Weigh at the same time each morning to separate water noise from fat change
- Review recent labs — A1C, fasting glucose, comprehensive metabolic panel
- Check for interfering medications — steroids, atypical antipsychotics, some beta-blockers raise glucose
- Rule out untreated sleep apnea, hypothyroidism, elevated cortisol — all blunt weight loss
If You Are Truly Plateaued: Options
| Option | When It Fits | Expected Benefit |
|---|---|---|
| Titrate Ozempic to 2 mg | Still on 0.5 or 1 mg and tolerating well | Additional 2–5% weight loss, 0.3–0.5 A1C |
| Switch to Wegovy (semaglutide 2.4 mg) | Primary goal is weight loss, commercial coverage | Up to 2.4 mg label dose |
| Switch to Mounjaro / Zepbound (tirzepatide) | Plateau persists on max semaglutide | Often an additional 5–10% weight loss |
| Add SGLT2 inhibitor | A1C still above target; CKD or heart failure risk | A1C −0.5 to −1.0; cardio-renal benefit |
| Add metformin if not yet on | Type 2 diabetes with some residual A1C elevation | A1C −0.5 to −1.0 |
| Refer for bariatric surgery | BMI still above threshold despite max GLP-1 | 20–35% weight loss; durable A1C improvement |
| Add intensive lifestyle | Any plateau with room to optimize | Variable; often 3–5% additional loss with resistance training + protein |
Do Not Just Stop
When semaglutide is discontinued, the STEP 1 extension trial data show about two-thirds of weight lost is regained within 12 months. A1C typically drifts up 0.5 to 1.0 percentage points. Most patients who “feel like Ozempic stopped working” and quit then realize the drug was working better than they appreciated. If you need to stop — cost, side effects, pregnancy planning — have a continuation plan with your clinician.
Clinical Scenarios
Scenario A: 0.5 mg, 8 months in, plateau at 8% loss
Titrate to 1 mg, then 2 mg if tolerated. Many patients get another 3 to 5 percent loss at the higher dose.
Scenario B: 1 mg, 14 months, 12% loss holding steady
Likely a real physiologic plateau. Focus on maintenance: resistance training, protein, sleep. Consider switching to tirzepatide only if further loss is clinically needed.
Scenario C: 1 mg, 6 months, initial 5% loss now regained
Investigate storage, technique, and diet drift first. Likely not true failure — address the reversible factors before changing medications.
Related Reading
See our treatment hub, A1C levels, and nutrition guides for the broader framework.
The Bottom Line
Does Ozempic stop working? True pharmacologic failure is uncommon. Most cases labeled “not working anymore” are either a normal plateau after 6 to 12 months of successful response, or a fixable issue — under-dose, technique error, storage problem, or calorie creep. Investigate before concluding failure. When a genuine plateau is reached, options include titrating to 2 mg, switching to tirzepatide, adding an SGLT2 inhibitor, or intensifying lifestyle. Do not stop without a plan: withdrawal typically brings back appetite, weight, and A1C within a year.
